The prediction of virulence based on presence of virulence genes in E. coli may not always be accurate

Gut Pathogens

Florian Gunzer¹  Trudy M Wassenaar² 

[1] Institute of Medical Microbiology and Hygiene, TU Dresden, Dresden, Germany;Molecular Microbiology and Genomics Consultants, Tannenstrasse 7, Zotzenheim, 55576, Germany

关键词: Pathogenicity;    Whole Genome Sequencing;    E. coli;    Virulence;   

Others  :  1217994
DOI  :  10.1186/s13099-015-0062-4

 received in 2015-05-05, accepted in 2015-06-04,  发布年份 2015

【 摘 要 】

Now that microbial whole genome sequencing is in reach of many researchers, it is common to infer virulent properties of a given bacterial isolate based on the presence of virulence genes. However, this may lead to inaccurate presumptions of virulence. Using the findings of a recent publication (Da Silva Santos et al. Gut Pathog 7:2, 2015) where virulence was inferred from a genome sequence and subsequently confirmed by in vitro analysis, we present an alternative view on the case described in that publication. Our alternative view point, which is further substantiated by whole genome sequencing of probiotic E. coli strains, may contribute to a more balanced vision on the interactions between pathogens and host.

【 授权许可】

   
2015 Wassenaar and Gunzer.

【 参考文献 】

• [1]Da Silva Santos AC, Gomes Romeiro F, Yukie Sassaki L, Rodrigues J. Escherichia coli from Crohn’s disease patient displays virulence features of enteroinvasive (EIEC), enterohemorragic (EHEC), and enteroaggregative (EAEC) pathotypes. Gut Pathogens. 2015; 7:2. BioMed Central Full Text
• [2]Moxon R, Tang C. Challenge of investigating biologically relevant functions of virulence factors in bacterial pathogens. Philos Trans Royal Soc B Biol Sci. 2000; 355(1397):643-656.
• [3]Wassenaar TM, Gaastra W. Bacterial virulence: can we draw the line? FEMS Microbiol Lett. 2001; 201:1-7.
• [4]Pallen MJ, Wren BW. Bacterial pathogenomics. Nature. 2007; 449:835-842.
• [5]Christensen GJ, Brüggemann H. Bacterial skin commensals and their role as host guardians. Benef Microbes. 2014; 5:201-215.
• [6]Muñoz P, Bouza E, Cuenca-Estrella M, Eiros JM, Pérez MJ, Sánchez-Somolinos M et al.. Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clin Infect Dis. 2005; 40:1625-1634.
• [7]de Llanos R, Querol A, Pemán J, Gobernado M, Fernández-Espinar MT. Food and probiotic strains from the Saccharomyces cerevisiae species as a possible origin of human systemic infections. Int J Food Microbiol. 2006; 110:286-290.
• [8]Stefanatou E, Kompoti M, Paridou A, Koutsodimitropoulos I, Giannopoulou P, Markou N et al.. Probiotic sepsis due to Saccharomyces fungaemia in a critically ill burn patient. Mycoses. 2011; 54:e643-e646.
• [9]Lukjancenko O, Wassenaar TM, Ussery DW. Comparison of 61 sequenced Escherichia coli genomes. Microb Ecol. 2010; 60:708-720.
• [10]Merhej V, Georgiades K, Raoult D. Postgenomic analysis of bacterial pathogens repertoire reveals genome reduction rather than virulence factors. Brief Funct Genomics. 2013; 12:291-304.
• [11]Santiago AE, Ruiz-Perez F, Jo NY, Vijayakumar V, Gong MQ, Nataro JP. A large family of antivirulence regulators modulates the effects of transcriptional activators in Gram-negative pathogenic bacteria. PLoS Pathog. 2014; 10(5):e1004153.
• [12]Vejborg RM, Friis C, Hancock V, Schembri MA, Klemm P. A virulent parent with probiotic progeny: comparative genomics of Escherichia coli strains CFT073, Nissle 1917 and ABU 83972. Mol Genet Genomics. 2010; 283:469-484.
• [13]Reister M, Hoffmeier K, Krezdorn N, Rotter B, Liang C, Rund S et al.. Complete genome sequence of the gram-negative probiotic Escherichia coli strain Nissle 1917. J Biotechnol. 2014; 187:106-107.
• [14]Kruis W, Fric P, Pokrotnieks J, Lukás M, Fixa B, Kascák M et al.. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut. 2004; 53:1617-1623.
• [15]Guenther K, Straube E, Pfister W, Guenther A, Huebler A. Sever sepsis after probiotic treatment with Escherichia coli NISSLE 1917. Pediatr Infect Dis J. 2010; 29:188-189.
• [16]Zhou CE, Smith J, Lam M, Zemla A, Dyer MD, Slezak T (2006) MvirDB-a microbial database of protein toxins, virulence factors and antibiotic resistance genes for bio-defence applications. Nucleic Acids Res 35(Database issue):D391–D394
• [17]Chen LH, Xiong ZH, Sun LL, Yang J, Jin Q (2012) VFDB 2012 update: toward the genetic diversity and molecular evolution of bacterial virulence factors. Nucleic Acids Res 4040(Database issue):D641–D645
• [18]Wassenaar TM, Zschüttig A, Beimfohr C, Geske T, Auerbach C, Cook H et al.. Virulence genes in a probiotic E. coli product with a recorded long history of safe use. Eur J Microbiol Immunol. 2015; 5:81-93.
• [19]Willenbrock H, Hallin PF, Wassenaar TM, Ussery DW. Characterization of probiotic Escherichia coli isolates with a novel pan-genome microarray. Genome Biol. 2007; 8:R267. BioMed Central Full Text
• [20]Rizzo G, Di Biase C. Haemolysin production in Escherichia coli strains isolated from urinary tract infection, infantile enteritis and commensal flora. Annali Sclavo. 1976; 18(6):841-848.
• [21]Hughes C, Müller D, Hacker J, Goebel W. Genetics and pathogenic role of Escherichia coli haemolysin. Toxicon. 1982; 20:247-252.
• [22]Wassenaar TM, Beimfohr C, Geske T, Zimmermann K. Voluntarily exposure to a single, high dose of probiotic Escherichia coli results in prolonged colonisation. Benef Microbes. 2014; 5:367-375.